Загрузка...
Use of rituximab as an induction therapy in anti-glomerular basement-membrane disease
BACKGROUND: Anti-glomerular basement-membrane (anti-GBM) disease (or Goodpasture disease) is characterized by severe kidney and lung involvement. Prognoses have improved with treatments that combine plasma exchange and immunosuppressive drugs. However, patients with severe renal involvement can have...
Сохранить в:
| Опубликовано в: : | BMC Nephrol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6149204/ https://ncbi.nlm.nih.gov/pubmed/30236081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1038-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|